πŸ’‰ Ipamorelin Research Protocol

ChemAesthetic | For research use only
10mg lyophilized peptide vial

βΈ»

πŸ”¬ Compound Overview

Ipamorelin is a selective growth hormone secretagogue and ghrelin receptor agonist, widely studied in research models for its GH-releasing properties with minimal off-target activity.

Unlike some earlier GHRPs, Ipamorelin has shown a more targeted mechanism in stimulating GH secretion without significantly affecting cortisol or prolactin levels.

Research studies have investigated its potential for:
β€’ Growth hormone modulation
β€’ Recovery-related signaling and cellular repair
β€’ Body composition regulation in GH-related models
β€’ Minimal desensitization with chronic exposure

Ipamorelin remains of interest for long-term GH secretion models and regenerative studies with lower systemic burden.

βΈ»

πŸ’§ Reconstitution Instructions

Reconstitute with sterile bacteriostatic water.
Swirl gently until dissolved β€” do not shake.

Vial Strength: 10mg vial
BAC Water Volume: 2ml
Final Concentration: 0.5mg per 0.1ml (10 units)

Using a 100-unit insulin syringe:
* 10 units = 0.5mg
* 20 units = 1mg

βΈ»

πŸ“ Dosing Guidelines (For Research Use Only)
β€’ Reference range: 200mcg – 1000mcg per injection
β€’ Frequency: 1–3x daily depending on research model
β€’ Administered subcutaneously in GH secretion studies
β€’ Clean vial top before each use

Often used alone or alongside GHRH analogues in GH/IGF-1 pathway investigations.

βΈ»

🧊 Storage

β€’ Store mixed peptide refrigerated at 2–8Β°C
β€’ Use within 60 days after reconstitution
β€’ Keep sealed and away from direct light

βΈ»

πŸ“Ž Legal & Research Notice

β€’ This product is for research use only
β€’ Not approved for human or veterinary use